De Sanctis V, Soliman A, Tzoulis P, Daar S, Kattamis A, Delaporta P, et al. The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients. Acta Biomed [Internet]. 2022 May 11 [cited 2024 Jul. 17];93(2):e2022162. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12056